Non-Steroidal Anti-inflammatory Drugs Market Future Trends Influencing Growth Through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Non-Steroidal Anti-inflammatory Drugs Market Over The 2026–2030 Period?
The non-steroidal anti-inflammatory drugs market has shown robust expansion in recent years. It is projected to rise from $21.89 billion in 2025 to $23.31 billion in 2026, at a compound annual growth rate (CAGR) of 6.5%. This growth in prior periods can be attributed to the increasing prevalence of arthritis and musculoskeletal disorders, greater awareness of pain management therapies, the expanding geriatric population, the proliferation of retail pharmacies, and advancements in drug formulation technologies.
The market for non-steroidal anti-inflammatory drugs is projected to experience robust expansion over the coming years. This market is forecast to reach $29.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.5%. This anticipated growth during the forecast period is driven by factors such as the increasing adoption of personalized medicine, the expansion of e-pharmacy platforms, enhanced research and development into new NSAID formulations, a greater prevalence of chronic inflammatory conditions, and the incorporation of digital health tools for monitoring pain. Key trends anticipated for the forecast period encompass tailored pain management solutions, a growing consumer demand for over-the-counter anti-inflammatory medications, the creation of fast-acting formulations, an emphasis on managing chronic pain and arthritis, and the broadening of online pharmacy distribution channels.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
Which Important Drivers Are Guiding The Non-Steroidal Anti-inflammatory Drugs Market Growth?
The non-steroidal anti-inflammatory drugs (NSAIDs) market and related pain management solutions are projected to grow going forward, driven by the increasing prevalence of chronic pain. Chronic pain is defined as persistent or recurrent pain lasting three months or longer, stemming from conditions such as arthritis, fibromyalgia, back pain, neuropathic pain, and other musculoskeletal disorders. These conditions considerably impact patients’ quality of life and frequently necessitate long-term management, including medication, physical therapy, and supportive care. The growing occurrence of chronic pain consequently increases the demand for effective pain relief therapies, such as NSAIDs and other analgesic formulations. For example, in October 2024, the National Center for Biotechnology Information, a US-based federal government research and information organization, stated that 24.3% of adults reported experiencing chronic pain, with 8.5% of adults reporting high-impact chronic pain that limits daily activities. Therefore, the expanding number of individuals suffering from chronic pain is expected to boost the demand for pain management therapies, thereby supporting the growth of the NSAIDs market and associated products.
What Are The Main Segments Within The Non-Steroidal Anti-inflammatory Drugs Market Segment Structure?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented –
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
What Trends Are Influencing The Evolution Of The Non-Steroidal Anti-inflammatory Drugs Market?
Key companies operating in the non-steroidal anti-inflammatory drugs (NSAIDs) market are prioritizing the development of innovative solutions, such as analgesic–gastroprotective combination formulations. This focus aims to address the growing demand for efficient pain relief while mitigating the gastrointestinal risks commonly linked to prolonged NSAID usage. These dual-action technologies pair an NSAID with a protective agent to sustain anti-inflammatory efficacy and simultaneously prevent stomach irritation, presenting a safer alternative to traditional single-agent NSAIDs. For example, in March 2024, Endo International plc, an Ireland-based pharmaceutical company, launched ibuprofen-famotidine 800 mg/26.6 mg tablets. This advanced formulation combines the pain-relieving and anti-inflammatory properties of ibuprofen with the gastroprotective benefits of famotidine. This tablet with dual functionality is engineered to relieve pain while reducing gastrointestinal side effects like ulcers or irritation, which frequently arise from extended NSAID therapy, thereby enhancing safety and improving patient adherence.
Who Are The Companies Participating In The Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company
Get The Full Non-Steroidal Anti-inflammatory Drugs Market Report:
Which Region Dominates The Non-Steroidal Anti-inflammatory Drugs Market By Market Share?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Non-Steroidal Anti-inflammatory Drugs Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Non-Steroidal Anti-inflammatory Drugs Market 2026, By The Business Research Company
Non Steroidal Anti Inflammatory Drugs Market Report 2026
Anti Inflammatory Therapeutics Market Report 2026
Rheumatoid Arthritis Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
